Clinical Trial

Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).

Study acronym: PolyPause
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the role of the gut microbiome and phageome in explaining interindividual variability in the metabolic response to polyphenol-rich nutraceuticals among menopausal women. Insights from this research will support the development of personalized nutrition strategies to improve quality of life and reduce cardiovascular disease (CVD) risk during menopause.
Trial Details
NCT Number NCT07182370
Lead Sponsor National Research Council, Spain
Collaborators: Hospital Universitario Virgen de la Arrixaca, IMDEA Food
Conditions Menopause Related Conditions, Cardiovascular Risk
Enrollment 90 participants
Start Date 2024-01-15
Primary Completion 2025-07-01 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-19